According to ImmunoPrecise Antibodies's latest financial reports the company's current revenue (TTM ) is A$29.06 Million. In 2023 the company made a revenue of A$25.68 Million an increase over the revenue in the year 2022 that were of A$22.64 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.